C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2002
11/27/2002	EP1259642A1 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002	EP1259540A1 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259534A2 Process for making granulated n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester
11/27/2002	EP1259531A2 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259528A1 Nucleic acids, proteins and antibodies
11/27/2002	EP1259526A2 Nucleic acids, proteins, and antibodies
11/27/2002	EP1221954A4 Methods for identifying inhibitors of methionine aminopeptidases
11/27/2002	EP0783316B1 Antifungal and antibiotic synthetic peptides
11/27/2002	CN1382155A Process for preparation of dipeptide and intermediate product in such process
11/27/2002	CN1382154A Basic monocyclic compounds having NK2 antagonist action processes for their preparation and formulations containing them
11/27/2002	CN1094943C Urethanes and ureas that induce cytokine production
11/27/2002	CN1094931C Antithrombotic organic nitrates
11/26/2002	US6486350 Biological reagents and methods for determining the mechanism in the generation of β-amyloid peptide
11/26/2002	US6486193 Antiarthritic agents; antiinflammatory agents
11/21/2002	WO2003099841A2 Peptides and the use thereof in darkening the skin
11/21/2002	WO2002092829A1 Process for producing peptide
11/21/2002	WO2002092781A2 Peptide compounds for counteracting reactive oxygen species and free radicals
11/21/2002	WO2002092774A2 Replicase cycling reaction amplification
11/21/2002	WO2002092622A2 Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors
11/21/2002	WO2002092620A2 Peptides and related molecules that bind to tall-1
11/21/2002	WO2002092566A1 Arginine derivatives
11/21/2002	WO2002018341A9 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
11/21/2002	US20020173530 Single morphic forms of metalloproteinase inhibitors
11/21/2002	US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002	US20020173468 Modified cytostatic agents
11/21/2002	US20020173452 Cytostatic-glycoconjugates having specifically cleavable linking units
11/21/2002	US20020173049 Controlling protein levels in eucaryotic organisms
11/21/2002	US20020173019 Enzymes for biopolymer production
11/21/2002	US20020173007 Human chemokine polypeptides
11/21/2002	US20020172962 Generation of nucleotide sequence ligands; obtain nucleotide sequences mixture, separate nucleotide sequences, amplify nucleotide sequences, incubate with modulator, detect adjustment in binding activity
11/21/2002	CA2449292A1 Dipeptide derivatives
11/21/2002	CA2447314A1 Arginine derivatives
11/21/2002	CA2447292A1 Peptide compounds for counteracting reactive oxygen species and free radicals
11/20/2002	EP1258491A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2002	EP1258476A1 Alpha-amino acid derivatives, method for their preparation and their use as dipeptidyl-peptidase IV inhibitors (DPP IV)
11/20/2002	EP0750507B1 Proteasome regulation of nf-kappa-b activity
11/19/2002	US6482943 Quinones as disease therapies
11/19/2002	US6482846 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/19/2002	US6482825 Growth-hormone secretagogues
11/19/2002	US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites
11/19/2002	CA2261579C Isolated peptides derived from mage-2
11/19/2002	CA2155931C Inhibitors of thrombosis
11/19/2002	CA2087325C Method of purifying .alpha.-l-aspartyl-l-phenylalanine methyl ester
11/16/2002	CA2383556A1 High-efficiency assay for protein mannosyl transferases
11/14/2002	WO2002090503A2 Anti-microbial peptides and compositions
11/14/2002	WO2002090380A1 Tetrapeptide stimulating the retinal function and the method of its application
11/14/2002	WO2002090314A1 Pyruvate derivatives
11/14/2002	WO2002089845A1 Remedies for sepsis
11/14/2002	WO2002089739A2 Peptide deformylase activated prodrugs
11/14/2002	WO2002081694A8 Method for the sectetion and production of protein
11/14/2002	WO2002062373A3 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
11/14/2002	US20020169318 Novel thrombin inhibitors
11/14/2002	US20020169177 Imidazole and benzimidazole caspase inhibitors and uses thereof
11/14/2002	US20020169133 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
11/14/2002	US20020169114 Formulation of boronic acid compounds
11/14/2002	US20020168628 Variant of LAV viruses
11/14/2002	CA2447470A1 Peptide deformylase activated prodrugs
11/14/2002	CA2446322A1 Anti-microbial peptides and compositions
11/13/2002	EP1256590A1 Method for synthesis of (2S,3aS,7aS)-1-(S)-alanyl-octahydro-1H-indole-2- carboxylic acid derivatives and use in the synthesis of perindopril
11/13/2002	EP1255864A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255845A2 Modified cytokines for use in cancer therapy
11/13/2002	EP1255817A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255778A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255777A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255776A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255769A2 Universal procedure for refolding recombinant proteins
11/13/2002	EP1255768A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255767A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255766A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/13/2002	EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002	EP1255570A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
11/13/2002	EP1255568A2 Conjugates targeted to target receptors
11/13/2002	EP1255542A1 Substituted amino acids as neutral sphingomyelinase inhibitors
11/13/2002	EP1086092B1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
11/13/2002	EP1007078A4 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties
11/13/2002	EP0699074B1 Thrombin inhibitors
11/13/2002	CN1379819A Catalytically active recombinant MEMAPSIN and methods of use thereof
11/13/2002	CN1379785A Caspase inhibitors for treatment and prevention of chemotherapy and radiation therapy induced cell death
11/12/2002	US6479460 Pseudopeptidic osteogenic growth polypeptide
11/12/2002	US6479265 Catalytic antibodies which hydrolyze primary amides and methods for eliciting and use of such antibodies
11/12/2002	US6479078 Substantially crystalline form of melagatran
11/12/2002	US6479055 Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
11/12/2002	CA2204535C Molecules that home to a selected organ or tissue in vivo and methods of identifying same
11/12/2002	CA2138647C Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
11/12/2002	CA2101227C Chlorophyll and bacteriochlorophyll derivatives and pharmaceutical compositions containing them
11/12/2002	CA2077102C Antibiotic ge 2270 factor c2a
11/07/2002	WO2002088664A2 Control of compactability through crystallization
11/07/2002	WO2002088318A2 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002	WO2002088172A2 Pentapeptide compounds and uses related thereto
11/07/2002	WO2002087548A1 A pharmaceutical tablet having a high api content
11/07/2002	WO2002087504A2 Methods for inhibiting tumor cell proliferation
11/07/2002	WO2002087362A1 Non-caking aspartame fine grade
11/07/2002	WO2002050084A3 Streptogramin derivatives preparation thereof and compositions containing same
11/07/2002	WO2001046220A3 Bioactive oligopeptides
11/07/2002	US20020165343 Growth hormone secretagogues
11/07/2002	US20020165230 Gamma-ketoacid dipeptides as inhibitors of caspase-3
11/07/2002	US20020165165 Free radical scavengers; also use as an amphiphilic lipid to form lipid vesicles; N-octyloxycarbonyl-beta-alanyl-L-histidine, for example
11/07/2002	US20020165164 New effectors of dipeptidyl peptidase IV for topical use

1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 307